» Articles » PMID: 36380021

Death by TNF: a Road to Inflammation

Overview
Journal Nat Rev Immunol
Date 2022 Nov 15
PMID 36380021
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics that neutralize TNF are among the most successful drugs for the treatment of chronic inflammatory and autoimmune pathologies. In recent years, it became clear that TNF drives inflammatory responses not only directly by inducing inflammatory gene expression but also indirectly by inducing cell death, instigating inflammatory immune reactions and disease development. Hence, inhibitors of cell death are being considered as a new therapy for TNF-dependent inflammatory diseases.

Citing Articles

Hypoxemia exerts detrimental effects on the choroid plexuses and cerebrospinal fluid system in rats.

Barakat R, Al-Sarraf H, Redzic Z Fluids Barriers CNS. 2025; 22(1):27.

PMID: 40075475 PMC: 11905537. DOI: 10.1186/s12987-024-00613-w.


TNF-α, An Inflammatory Path, Rerouted Through Alternate Medicinal Channels.

Shanker S, Kumar K, Hussain S, Hariharan A, Ramasamy T J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4514-S4516.

PMID: 40061663 PMC: 11888719. DOI: 10.4103/jpbs.jpbs_1058_24.


Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases.

Mahjoubin-Tehran M, Rezaei S, Butler A, Sahebkar A Inflamm Res. 2025; 74(1):47.

PMID: 40047902 DOI: 10.1007/s00011-025-02021-8.


Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.

Lai G, Lee Y, Weng H, Lai K, Hsiang M, Hsu K Cell Death Discov. 2025; 11(1):83.

PMID: 40025071 PMC: 11873111. DOI: 10.1038/s41420-025-02367-2.


Exploring the association between rheumatoid arthritis and non-small cell lung cancer risk: a transcriptomic and drug target-based analysis.

Wang L, Dong Y, Yang Q, Liu S, Wu B, Zhang D Hereditas. 2025; 162(1):28.

PMID: 40016789 PMC: 11866852. DOI: 10.1186/s41065-025-00396-6.


References
1.
Anderton H, Wicks I, Silke J . Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease. Nat Rev Rheumatol. 2020; 16(9):496-513. DOI: 10.1038/s41584-020-0455-8. View

2.
CARSWELL E, Old L, Kassel R, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMC: 433057. DOI: 10.1073/pnas.72.9.3666. View

3.
Coley W . The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med. 2009; 3(Surg Sect):1-48. PMC: 1961042. View

4.
Pennica D, Nedwin G, Hayflick J, Seeburg P, Derynck R, Palladino M . Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984; 312(5996):724-9. DOI: 10.1038/312724a0. View

5.
Marmenout A, Fransen L, Tavernier J, Van der Heyden J, Tizard R, Kawashima E . Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem. 1985; 152(3):515-22. DOI: 10.1111/j.1432-1033.1985.tb09226.x. View